item,route,main.route,class,dn,FORM_STRENGTH,atc
01622J,Oral,Oral,Chemotherapy,METHOTREXATE,Tablet 2.5 mg,L01BA01
01623K,Oral,Oral,Chemotherapy,METHOTREXATE,Tablet 10 mg,L01BA01
02272N,Oral,Oral,Chemotherapy,METHOTREXATE,Tablet 10 mg,L01BA01
04319H,IV,Parenteral,Chemotherapy,CISPLATIN,I.V. injection 50 mg in 50 mL,L01XA01
10148D,IV,Parenteral,Chemotherapy,DOCETAXEL,Solution concentrate for I.V. infusion 160 mg in 16 mL,L01CD02
01598D,Oral,Oral,Chemotherapy,MERCAPTOPURINE,Tablet containing mercaptopurine monohydrate 50 mg,L01BB02
08820F,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 20 mg,L01AX03
09361Q,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 140 mg,L01AX03
10062N,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 180 mg,L01AX03
08821G,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 100 mg,L01AX03
08380C,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 100 mg,L01AX03
04327R,Injection,Parenteral,Chemotherapy,CYCLOPHOSPHAMIDE,Powder for injection 1 g (anhydrous),L01AA01
04375G,Injection,Parenteral,Chemotherapy,EPIRUBICIN,Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL,L01DB03
04394G,Injection,Parenteral,Chemotherapy,FLUOROURACIL,Injection 5000 mg in 100 mL,L01BC02
04567J,IV,Parenteral,Chemotherapy,PACLITAXEL,Solution concentrate for I.V. infusion 150 mg in 25 mL,L01CD01
07246J,IV,Parenteral,Chemotherapy,GEMCITABINE,Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL,L01BC05
07253R,IV,Parenteral,Chemotherapy,OXALIPLATIN,Solution concentrate for I.V. infusion 50 mg in 10 mL,L01XA03
08362D,Oral,Oral,Chemotherapy,CAPECITABINE,Tablet 500 mg,L01BC06
07226H,Injection,Parenteral,Chemotherapy,CYCLOPHOSPHAMIDE,Powder for injection 1 g (anhydrous),L01AA01
07254T,IV,Parenteral,Chemotherapy,PACLITAXEL,Solution concentrate for I.V. infusion 150 mg in 25 mL,L01CD01
07222D,IV,Parenteral,Chemotherapy,CARBOPLATIN,Solution for I.V. injection 450 mg in 45 mL,L01XA02
07255W,IV,Parenteral,Chemotherapy,PEMETREXED,Powder for I.V. infusion 100 mg (as disodium),L01BA04
02395C,Injection,Parenteral,Chemotherapy,METHOTREXATE,Injection 50 mg in 2 mL vial,L01BA01
09544H,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
10881Q,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
04309T,IV,Parenteral,Chemotherapy,CARBOPLATIN,Solution for I.V. injection 450 mg in 45 mL,L01XA02
03093T,Oral,Oral,Chemotherapy,HYDROXYCARBAMIDE (HYDROXYUREA),Capsule 500 mg,L01XX05
04542C,IV,Parenteral,Chemotherapy,OXALIPLATIN,Solution concentrate for I.V. infusion 50 mg in 10 mL,L01XA03
04400N,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
10026Q,Oral,Oral,Chemotherapy,CYCLOPHOSPHAMIDE,Tablet 50 mg (as monohydrate),L01AA01
04706Q,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
01266P,Oral,Oral,Chemotherapy,CYCLOPHOSPHAMIDE,Tablet 50 mg (anhydrous),L01AA01
04620E,IV,Parenteral,Chemotherapy,VINORELBINE,Solution for I.V. infusion 10 mg (as tartrate) in 1 mL,L01CA04
09010F,Oral,Oral,Chemotherapy,VINORELBINE,Capsule 30 mg (as tartrate),L01CA04
07239B,Injection,Parenteral,Chemotherapy,FLUOROURACIL,Injection 5000 mg in 100 mL,L01BC02
07234R,Injection,Parenteral,Chemotherapy,FLUOROURACIL,Injection 5000 mg in 100 mL,L01BC02
07237X,IV,Parenteral,Chemotherapy,ETOPOSIDE,Powder for I.V. infusion 100 mg (as phosphate),L01CB01
07224F,IV,Parenteral,Chemotherapy,CISPLATIN,I.V. injection 50 mg in 50 mL,L01XA01
07229L,IV,Parenteral,Chemotherapy,DOXORUBICIN,Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial,L01DB01
04361M,IV,Parenteral,Chemotherapy,DOXORUBICIN,Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial,L01DB01
04632T,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
04639E,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
04703M,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10475H,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
10424P,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
08769M,Oral,Oral,Targeted,GEFITINIB,Tablet 250 mg,L01EB01
07262F,IV,Parenteral,Chemotherapy,VINCRISTINE,I.V. injection containing vincristine sulfate 1 mg in 1 mL,L01CA02
07258B,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
04403R,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
04439P,IV,Parenteral,Chemotherapy,GEMCITABINE,Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL,L01BC05
10158P,IV,Parenteral,Chemotherapy,DOCETAXEL,Solution concentrate for I.V. infusion 160 mg in 16 mL,L01CD02
07231N,Injection,Parenteral,Chemotherapy,EPIRUBICIN,Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL,L01DB03
01163F,Oral,Oral,Chemotherapy,CHLORAMBUCIL,Tablet 2 mg,L01AA02
04615X,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
04619D,IV,Parenteral,Chemotherapy,VINCRISTINE,I.V. injection containing vincristine sulfate 1 mg in 1 mL,L01CA02
11213E,Oral,Oral,Targeted,IBRUTINIB,Capsule 140 mg,L01EL01
01389D,Oral,Oral,Chemotherapy,ETOPOSIDE,Capsule 100 mg,L01CB01
07257Y,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
02547C,Oral,Oral,Chemotherapy,MELPHALAN,Tablet 2 mg,L01AA03
10193L,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
04451G,IV,Parenteral,Chemotherapy,IRINOTECAN,I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL,L01CE02
04431F,Injection,Parenteral,Chemotherapy,FLUOROURACIL,Injection 5000 mg in 100 mL,L01BC02
07263G,IV,Parenteral,Chemotherapy,VINORELBINE,Solution for I.V. infusion 10 mg (as tartrate) in 1 mL,L01CA04
09362R,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 140 mg,L01AX03
07238Y,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
04428C,IV,Parenteral,Chemotherapy,ETOPOSIDE,Powder for I.V. infusion 100 mg (as phosphate),L01CB01
04433H,Injection,Parenteral,Chemotherapy,BLEOMYCIN,"Powder for injection containing bleomycin sulfate 15,000 I.U.",L01DC01
11553C,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
07249M,IV,Parenteral,Chemotherapy,IRINOTECAN,I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL,L01CE02
04600D,IV,Parenteral,Chemotherapy,PEMETREXED,Powder for I.V. infusion 100 mg (as disodium),L01BA04
10618W,Oral,Oral,Targeted,RUXOLITINIB,Tablet 20 mg,L01EJ01
10617T,Oral,Oral,Targeted,RUXOLITINIB,Tablet 20 mg,L01EJ01
10391X,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10267J,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
10333W,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
10401K,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
07268M,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
11106M,Oral,Oral,Targeted,NINTEDANIB,Capsule 150 mg,L01EX09
10179R,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11419B,Oral,Oral,Targeted,IBRUTINIB,Capsule 140 mg,L01EL01
10775D,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
10748Q,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
01128J,Oral,Oral,Chemotherapy,BUSULFAN,Tablet 2 mg,L01AB01
07244G,Injection,Parenteral,Chemotherapy,BLEOMYCIN,"Powder for injection containing bleomycin sulfate 15,000 I.U.",L01DC01
08361C,Oral,Oral,Chemotherapy,CAPECITABINE,Tablet 150 mg,L01BC06
09148L,Oral,Oral,Targeted,LAPATINIB,Tablet 250 mg (as ditosilate monohydrate),L01EH01
10381J,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10383L,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10402L,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
07230M,IV,Parenteral,Chemotherapy,DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL,L01DB01
10140Q,IV,Parenteral,Chemotherapy,ERIBULIN,Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL,L01XX41
11264W,Oral,Oral,Targeted,GEFITINIB,Tablet 250 mg,L01EB01
11622Q,Oral,Oral,Targeted,OSIMERTINIB,Tablet 80 mg,L01EB04
02985D,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
04614W,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
10760H,Injection,Parenteral,Chemotherapy,BENDAMUSTINE,Powder for injection containing bendamustine hydrochloride 100 mg,L01AA09
07274W,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
04393F,IV,Parenteral,Chemotherapy,FLUDARABINE,Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL,L01BB05
11162L,Oral,Oral,Targeted,IDELALISIB,Tablet 150 mg,L01EM01
10150F,IV,Parenteral,Chemotherapy,NANOPARTICLE ALBUMIN-BOUND PACLITAXEL,Powder for I.V. injection containing 100 mg paclitaxel,L01CD01
07223E,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
07273T,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
07240C,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
10334X,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
10308M,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
10965D,Oral,Oral,Targeted,LENVATINIB,Capsule 10 mg (as mesilate),L01EX08
10952K,Oral,Oral,Targeted,LENVATINIB,Capsule 4 mg (as mesilate),L01EX08
11158G,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11153B,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
07236W,Injection,Parenteral,Chemotherapy,CABAZITAXEL,"Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent",L01CD04
08381D,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 250 mg,L01AX03
08819E,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 5 mg,L01AX03
07275X,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
10382K,Oral,Oral,Targeted,TRAMETINIB,Tablet 2 mg,L01EE01
02846T,Oral,Oral,Targeted,DABRAFENIB,Capsule 75 mg (as mesilate),L01EC02
10405P,Oral,Oral,Targeted,TRAMETINIB,Tablet 2 mg,L01EE01
10003L,Oral,Oral,Targeted,DABRAFENIB,Capsule 75 mg (as mesilate),L01EC02
10593M,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
04650R,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
07267L,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11956G,IV,Parenteral,Targeted,TRASTUZUMAB EMTANSINE,Powder for I.V. infusion 100 mg,L01XC14
07227J,Injection,Parenteral,Chemotherapy,CYTARABINE,Injection 100 mg in 5 mL vial,L01BC01
07251P,IV,Parenteral,Chemotherapy,METHOTREXATE,Solution concentrate for I.V. infusion 5000 mg in 50 mL vial,L01BA01
04448D,IV,Parenteral,Chemotherapy,IFOSFAMIDE,Powder for I.V. injection 1 g,L01AA06
11309F,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
10615Q,Oral,Oral,Targeted,RUXOLITINIB,Tablet 15 mg,L01EJ01
10616R,Oral,Oral,Targeted,RUXOLITINIB,Tablet 5 mg,L01EJ01
10927D,Oral,Oral,Targeted,RUXOLITINIB,Tablet 10 mg,L01EJ01
11435W,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
02641B,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 200 mg in 40 mL,L01XC11
11494Y,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
02638W,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 200 mg in 40 mL,L01XC11
01396L,Oral,Oral,Chemotherapy,ETOPOSIDE,Capsule 50 mg,L01CB01
07242E,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
10265G,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
10165B,IV,Parenteral,Chemotherapy,NANOPARTICLE ALBUMIN-BOUND PACLITAXEL,Powder for I.V. injection containing 100 mg paclitaxel,L01CD01
09422X,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
10459L,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
10132G,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
10540R,Oral,Oral,Targeted,AXITINIB,Tablet 5 mg,L01EK01
10572K,Oral,Oral,Targeted,AXITINIB,Tablet 1 mg,L01EK01
10539Q,Oral,Oral,Targeted,AXITINIB,Tablet 1 mg,L01EK01
11159H,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11157F,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11369J,Oral,Oral,Targeted,CABOZANTINIB,Tablet 40 mg,L01EX07
11368H,Oral,Oral,Targeted,CABOZANTINIB,Tablet 40 mg,L01EX07
10172J,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
10180T,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
10423N,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
01309X,Oral,Oral,Targeted,NILOTINIB,Capsule 150 mg (as hydrochloride monohydrate),L01EA03
07261E,IV,Parenteral,Chemotherapy,VINBLASTINE,Solution for I.V. injection containing vinblastine sulfate 10 mg in 10 mL,L01CA01
11397W,Oral,Oral,Targeted,RIBOCICLIB,Tablet 200 mg,L01EF02
11385F,Oral,Oral,Targeted,RIBOCICLIB,Tablet 200 mg,L01EF02
11386G,Oral,Oral,Targeted,RIBOCICLIB,Tablet 200 mg,L01EF02
10069Y,IV,Parenteral,Targeted,PANITUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC08
07266K,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
07243F,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
07250N,IV,Parenteral,Chemotherapy,METHOTREXATE,Solution concentrate for I.V. infusion 5000 mg in 50 mL vial,L01BA01
11143L,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11906P,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
08378Y,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 5 mg,L01AX03
10120P,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
10114H,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
10121Q,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
07225G,Injection,Parenteral,Chemotherapy,CLADRIBINE,Injection 10 mg in 5 mL,L01BB04
04436L,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
04731B,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
10014C,Oral,Oral,Targeted,ERLOTINIB,Tablet 150 mg (as hydrochloride),L01EB02
11792P,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11297N,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
07233Q,IV,Parenteral,Chemotherapy,FLUDARABINE,Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL,L01BB05
04613T,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11630D,Oral,Oral,Targeted,VENETOCLAX,Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14  tablets venetoclax 100 mg,L01XX52
11911X,IV,Parenteral,Immunotherapy,DURVALUMAB,Solution concentrate for I.V. infusion 120 mg in 2.4 mL,L01XC28
09417P,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
04326Q,Injection,Parenteral,Chemotherapy,CLADRIBINE,Injection 10 mg in 5 mL,L01BB04
11524M,Oral,Oral,Chemotherapy,TRIFLURIDINE + TIPIRACIL,Tablet containing 20 mg trifluridine with 8.19 mg tipiracil (as hydrochloride),L01BC59
09597D,Injection,Parenteral,Chemotherapy,AZACITIDINE,Powder for injection 100 mg,L01BC07
09598E,Injection,Parenteral,Chemotherapy,AZACITIDINE,Powder for injection 100 mg,L01BC07
01233X,Oral,Oral,Chemotherapy,TIOGUANINE,Tablet 40 mg,L01BB03
07252Q,Injection,Parenteral,Chemotherapy,MITOZANTRONE,Injection 20 mg (as hydrochloride) in 10 mL,L01DB07
11284X,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11277M,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
04531L,IV,Parenteral,Chemotherapy,NANOPARTICLE ALBUMIN-BOUND PACLITAXEL,Powder for I.V. injection containing 100 mg paclitaxel,L01CD01
07270P,IV,Parenteral,Chemotherapy,NANOPARTICLE ALBUMIN-BOUND PACLITAXEL,Powder for I.V. injection containing 100 mg paclitaxel,L01CD01
11492W,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
06100C,Injection,Parenteral,Chemotherapy,AZACITIDINE,Powder for injection 100 mg,L01BC07
06138C,Injection,Parenteral,Chemotherapy,AZACITIDINE,Powder for injection 100 mg,L01BC07
08379B,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 20 mg,L01AX03
04364Q,IV,Parenteral,Chemotherapy,DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL,L01DB01
10576P,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
10041L,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
10043N,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
09419R,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
04429D,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
02030W,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
11261Q,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
10742J,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
10322G,Oral,Oral,Targeted,CRIZOTINIB,Capsule 250 mg,L01ED01
11226W,Oral,Oral,Targeted,ALECTINIB,Capsule 150 mg,L01ED03
01818Q,Injection,Parenteral,Chemotherapy,METHOTREXATE,Injection 50 mg in 2 mL vial,L01BA01
11259N,Oral,Oral,Targeted,ERLOTINIB,Tablet 150 mg (as hydrochloride),L01EB02
04357H,Injection,Parenteral,Chemotherapy,CYTARABINE,Injection 100 mg in 5 mL vial,L01BC01
11552B,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
05444M,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11788K,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
02837H,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
11250D,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
04512L,IV,Parenteral,Chemotherapy,METHOTREXATE,Solution concentrate for I.V. infusion 5000 mg in 50 mL vial,L01BA01
10703H,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
09114Q,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
09113P,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11752M,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
10513H,IV,Parenteral,Targeted,PANITUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC08
10699D,Injection,Parenteral,Chemotherapy,ARSENIC,Injection concentrate containing arsenic trioxide 10 mg in 10 mL,L01XX27
10020J,Oral,Oral,Targeted,ERLOTINIB,Tablet 100 mg (as hydrochloride),L01EB02
10019H,Oral,Oral,Targeted,ERLOTINIB,Tablet 100 mg (as hydrochloride),L01EB02
11260P,Oral,Oral,Targeted,ERLOTINIB,Tablet 100 mg (as hydrochloride),L01EB02
10763L,Injection,Parenteral,Chemotherapy,BENDAMUSTINE,Powder for injection containing bendamustine hydrochloride 100 mg,L01AA09
11457B,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
10720F,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
10493G,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
10745M,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
10581X,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10595P,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10262D,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
10614P,Oral,Oral,Targeted,RUXOLITINIB,Tablet 5 mg,L01EJ01
09184J,Oral,Oral,Chemotherapy,FLUDARABINE,Tablet containing fludarabine phosphate 10 mg,L01BB05
10743K,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
11100F,Oral,Oral,Targeted,NINTEDANIB,Capsule 100 mg,L01EX09
10082P,IV,Parenteral,Targeted,PANITUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC08
10719E,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
09380Q,Oral,Oral,Targeted,SORAFENIB,Tablet 200 mg (as tosilate),L01EX02
10226F,Oral,Oral,Targeted,SORAFENIB,Tablet 200 mg (as tosilate),L01EX02
10237T,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 1000 mg in 50 mL,L01XC10
10239X,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 1000 mg in 50 mL,L01XC10
11784F,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
02819J,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
11257L,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
11632F,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
10403M,Oral,Oral,Targeted,TRAMETINIB,Tablet 500 micrograms,L01EE01
02438H,Oral,Oral,Chemotherapy,TEMOZOLOMIDE,Capsule 180 mg,L01AX03
11089P,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11067L,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11086L,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
04618C,IV,Parenteral,Chemotherapy,VINBLASTINE,Solution for I.V. injection containing vinblastine sulfate 10 mg in 10 mL,L01CA01
10025P,Oral,Oral,Targeted,ERLOTINIB,Tablet 150 mg (as hydrochloride),L01EB02
08898H,IV,Parenteral,Chemotherapy,CARMUSTINE,"Implants 7.7 mg, 8",L01AD01
02201W,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
04376H,Injection,Parenteral,Chemotherapy,CABAZITAXEL,"Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent",L01CD04
09611W,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11749J,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11152Y,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11915D,IV,Parenteral,Immunotherapy,DURVALUMAB,Solution concentrate for I.V. infusion 120 mg in 2.4 mL,L01XC28
10282E,IV,Parenteral,Targeted,TRASTUZUMAB EMTANSINE,Powder for I.V. infusion 100 mg,L01XC14
10281D,IV,Parenteral,Targeted,TRASTUZUMAB EMTANSINE,Powder for I.V. infusion 100 mg,L01XC14
11507P,Oral,Oral,Chemotherapy,TRIFLURIDINE + TIPIRACIL,Tablet containing 15 mg trifluridine with 6.14 mg tipiracil (as hydrochloride),L01BC59
07248L,IV,Parenteral,Chemotherapy,IFOSFAMIDE,Powder for I.V. injection 1 g,L01AA06
11229B,Injection,Parenteral,Chemotherapy,CARFILZOMIB,Powder for injection 30 mg,L01XG02
11698Q,Oral,Oral,Targeted,PALBOCICLIB,Capsule 125 mg,L01EF01
04502Y,IV,Parenteral,Chemotherapy,METHOTREXATE,Solution concentrate for I.V. infusion 5000 mg in 50 mL vial,L01BA01
11927R,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
10269L,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11638M,Oral,Oral,Targeted,LENVATINIB,Capsule 4 mg (as mesilate),L01EX08
11456Y,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
10214N,Oral,Oral,Chemotherapy,MERCAPTOPURINE,"Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL",L01BB02
11900H,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
09112N,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
09111M,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11787J,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
07247K,IV,Parenteral,Chemotherapy,IDARUBICIN,Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL,L01DB06
11543M,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
01416M,Oral,Oral,Targeted,DASATINIB,Tablet 100 mg,L01EA02
01354G,Oral,Oral,Targeted,DASATINIB,Tablet 20 mg,L01EA02
10418H,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
12199C,Oral,Oral,Targeted,VENETOCLAX,Tablet 100 mg,L01XX52
11532Y,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
04732C,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
02396D,Injection,Parenteral,Chemotherapy,METHOTREXATE,Injection 5 mg in 2 mL vial,L01BA01
02029T,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
02035D,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01XE11
10268K,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
11771M,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11878E,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11627Y,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11644W,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 50 mg in 10 mL,L01XC11
11926Q,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11929W,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
10144X,IV,Parenteral,Chemotherapy,ERIBULIN,Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL,L01XX41
10133H,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
09009E,Oral,Oral,Chemotherapy,VINORELBINE,Capsule 20 mg (as tartrate),L01CA04
11639N,Oral,Oral,Targeted,VENETOCLAX,Tablet 100 mg,L01XX52
10589H,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10597R,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
10764M,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11462G,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11230C,Injection,Parenteral,Chemotherapy,CARFILZOMIB,Powder for injection 30 mg,L01XG02
10682F,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
10916M,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11359W,Oral,Oral,Targeted,AFATINIB,Tablet 40 mg,L01EB03
11348G,Oral,Oral,Targeted,AFATINIB,Tablet 30 mg,L01EB03
04312Y,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
04712B,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
11951B,IV,Parenteral,Targeted,TRASTUZUMAB EMTANSINE,Powder for I.V. infusion 100 mg,L01XC14
10131F,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
10556N,Oral,Oral,Targeted,AXITINIB,Tablet 5 mg,L01EK01
09177B,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
09175X,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
07269N,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
07271Q,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
04435K,IV,Parenteral,Targeted,CETUXIMAB,Solution for I.V. infusion 500 mg in 100 mL,L01XC06
07260D,IV,Parenteral,Chemotherapy,TOPOTECAN,Powder for I.V. infusion 4 mg (as hydrochloride),L01CE01
11695M,IV,Parenteral,Immunotherapy,AVELUMAB,Solution concentrate for I.V. infusion 200 mg in 10 mL,L01XC31
11671G,IV,Parenteral,Immunotherapy,AVELUMAB,Solution concentrate for I.V. infusion 200 mg in 10 mL,L01XC31
10710Q,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
10619X,Oral,Oral,Targeted,RUXOLITINIB,Tablet 15 mg,L01EJ01
09418Q,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
09421W,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
09420T,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
11150W,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11360X,Oral,Oral,Targeted,CABOZANTINIB,Tablet 60 mg,L01EX07
11779Y,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11785G,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11138F,Oral,Oral,Chemotherapy,VORINOSTAT,Capsule 100 mg,L01XH01
11141J,Oral,Oral,Chemotherapy,VORINOSTAT,Capsule 100 mg,L01XH01
11651F,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11661R,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11789L,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11778X,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11056X,Oral,Oral,Targeted,CERITINIB,Capsule 150 mg,L01ED02
11076Y,Oral,Oral,Targeted,VEMURAFENIB,Tablet 240 mg,L01EC01
11074W,Oral,Oral,Targeted,COBIMETINIB,Tablet 20 mg,L01EE02
10436G,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
11347F,Oral,Oral,Targeted,AFATINIB,Tablet 40 mg,L01EB03
11704B,Injection,Parenteral,Chemotherapy,BLEOMYCIN,"Powder for injection containing bleomycin sulfate 15,000 I.U. in 1 vial",L01DC01
11626X,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
10885X,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
10407R,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11434T,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
09342Q,Oral,Oral,Targeted,DASATINIB,Tablet 100 mg,L01EA02
10047T,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
11160J,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11628B,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 50 mg in 10 mL,L01XC11
11642R,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
12157W,Oral,Oral,Targeted,OLAPARIB,Tablet 150 mg,L01XK01
09490L,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
11256K,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
11699R,Oral,Oral,Targeted,PALBOCICLIB,Capsule 75 mg,L01EF01
10473F,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
11374P,Oral,Oral,Targeted,CABOZANTINIB,Tablet 20 mg,L01EX07
04617B,IV,Parenteral,Chemotherapy,TOPOTECAN,Powder for I.V. infusion 4 mg (as hydrochloride),L01CE01
10504W,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
11775R,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
07259C,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11070P,Oral,Oral,Targeted,VISMODEGIB,Capsule 150 mg,L01XJ01
07265J,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11700T,Oral,Oral,Targeted,PALBOCICLIB,Capsule 100 mg,L01EF01
10324J,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
07256X,IV,Parenteral,Chemotherapy,RALTITREXED,Powder for I.V. infusion 2 mg in single use vial,L01BA03
10508C,IV,Parenteral,Targeted,PANITUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC08
10744L,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
10913J,Oral,Oral,Targeted,RUXOLITINIB,Tablet 10 mg,L01EJ01
11753N,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
04440Q,IV,Parenteral,Chemotherapy,IDARUBICIN,Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL,L01DB06
11782D,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
09179D,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
12122B,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
10115J,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11199K,IV,Parenteral,Chemotherapy,ERIBULIN,Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL,L01XX41
10135K,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
11080E,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
12121Y,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
07264H,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
01381Q,Oral,Oral,Targeted,DASATINIB,Tablet 50 mg,L01EA02
01415L,Oral,Oral,Targeted,DASATINIB,Tablet 70 mg,L01EA02
11928T,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11961M,Oral,Oral,Targeted,BINIMETINIB,Tablet 15 mg,L01EE03
11938H,Oral,Oral,Targeted,ENCORAFENIB,Capsule 75 mg,L01EC03
11949X,Oral,Oral,Targeted,ENCORAFENIB,Capsule 75 mg,L01EC03
10798H,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
10803N,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
11411N,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
09124F,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
09127J,Oral,Oral,Targeted,DASATINIB,Tablet 70 mg,L01EA02
09126H,Oral,Oral,Targeted,DASATINIB,Tablet 50 mg,L01EA02
11453T,Oral,Oral,Targeted,PONATINIB,Tablet 45 mg (as hydrochloride),L01EA05
10523W,Oral,Oral,Targeted,PONATINIB,Tablet 15 mg (as hydrochloride),L01EA05
10524X,Oral,Oral,Targeted,PONATINIB,Tablet 45 mg (as hydrochloride),L01EA05
11425H,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
10362J,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
02842N,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
10009T,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
09123E,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
10242C,Oral,Oral,Targeted,SORAFENIB,Tablet 200 mg (as tosilate),L01EX02
02954L,Oral,Oral,Targeted,DABRAFENIB,Capsule 50 mg (as mesilate),L01EC02
11819C,Oral,Oral,Targeted,TRAMETINIB,Tablet 2 mg,L01EE01
11823G,Oral,Oral,Targeted,DABRAFENIB,Capsule 75 mg (as mesilate),L01EC02
11646Y,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11252F,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
10591K,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 100 mg in 10 mL,L01XC02
12166H,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
12167J,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11293J,IV,Parenteral,Chemotherapy,PRALATREXATE,Solution for I.V. infusion 20 mg in 1 mL,L01BA05
11539H,Oral,Oral,Targeted,OLAPARIB,Tablet 150 mg,L01XK01
11679Q,IV,Parenteral,Immunotherapy,AVELUMAB,Solution concentrate for I.V. infusion 200 mg in 10 mL,L01XC31
11685B,IV,Parenteral,Immunotherapy,AVELUMAB,Solution concentrate for I.V. infusion 200 mg in 10 mL,L01XC31
11352L,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
11254H,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
09489K,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
11253G,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
11772N,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
12033H,Oral,Oral,Chemotherapy,TRIFLURIDINE + TIPIRACIL,Tablet containing 20 mg trifluridine with 8.19 mg tipiracil (as hydrochloride),L01BC59
12056M,Oral,Oral,Chemotherapy,TRIFLURIDINE + TIPIRACIL,Tablet containing 15 mg trifluridine with 6.14 mg tipiracil (as hydrochloride),L01BC59
10385N,Oral,Oral,Targeted,TRAMETINIB,Tablet 500 micrograms,L01EE01
12165G,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
12164F,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
10575N,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11762C,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11503K,Oral,Oral,Targeted,OLAPARIB,Tablet 100 mg,L01XK01
11034R,Oral,Oral,Targeted,OLAPARIB,Capsule 50 mg,L01XX46
11050N,Oral,Oral,Targeted,OLAPARIB,Capsule 50 mg,L01XK01
11458C,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11468N,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11727F,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11731K,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
02232L,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
10054E,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
10052C,Oral,Oral,Targeted,PAZOPANIB,Tablet 400 mg (as hydrochloride),L01EX03
10709P,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
11081F,Oral,Oral,Targeted,VEMURAFENIB,Tablet 240 mg,L01EC01
11075X,Oral,Oral,Targeted,COBIMETINIB,Tablet 20 mg,L01EE02
11267B,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
10588G,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11598K,Oral,Oral,Targeted,EVEROLIMUS,"Tablet, dispersible, 5 mg",L01EG02
11272G,IV,Parenteral,Chemotherapy,PRALATREXATE,Solution for I.V. infusion 20 mg in 1 mL,L01BA05
11807K,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11371L,Oral,Oral,Targeted,CABOZANTINIB,Tablet 20 mg,L01EX07
02034C,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01XE11
11542L,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
04514N,Injection,Parenteral,Chemotherapy,MITOZANTRONE,Injection 20 mg (as hydrochloride) in 10 mL,L01DB07
07272R,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
10309N,IV,Parenteral,Targeted,PERTUZUMAB,Solution for I.V. infusion 420 mg in 14 mL,L01XC13
11805H,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
12117R,Oral,Oral,Targeted,ACALABRUTINIB,Capsule 100 mg,L01EL02
11460E,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11455X,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
11304Y,Oral,Oral,Targeted,SONIDEGIB,Capsule 200 mg,L01XJ02
11636K,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11592D,Oral,Oral,Targeted,EVEROLIMUS,"Tablet, dispersible, 5 mg",L01EG02
11258M,Oral,Oral,Targeted,EVEROLIMUS,Tablet 2.5 mg,L01EG02
11263T,Oral,Oral,Targeted,ERLOTINIB,Tablet 25 mg (as hydrochloride),L01EB02
10028T,Oral,Oral,Targeted,ERLOTINIB,Tablet 25 mg (as hydrochloride),L01EB02
07245H,Injection,Parenteral,Chemotherapy,FOTEMUSTINE,Powder for injection 208 mg with solvent,L01AD05
11171Y,Oral,Oral,Targeted,IDELALISIB,Tablet 100 mg,L01EM01
09488J,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
11701W,Injection,Parenteral,Chemotherapy,BLEOMYCIN,"Powder for injection containing bleomycin sulfate 15,000 I.U. in 1 vial",L01DC01
11809M,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11948W,Oral,Oral,Targeted,BINIMETINIB,Tablet 15 mg,L01EE03
10249K,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC10
10236R,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 1000 mg in 50 mL,L01XC10
10708N,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
10010W,Oral,Oral,Targeted,SUNITINIB,Capsule 50 mg,L01EX01
11165P,Oral,Oral,Targeted,IDELALISIB,Tablet 150 mg,L01EM01
11935E,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
10741H,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
11073T,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11664X,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11758W,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11868P,Oral,Oral,Targeted,ABEMACICLIB,Tablet 150 mg,L01EF03
11786H,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
10503T,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
10691Q,Injection,Parenteral,Chemotherapy,ARSENIC,Injection concentrate containing arsenic trioxide 10 mg in 10 mL,L01XX27
11522K,Oral,Oral,Targeted,OLAPARIB,Tablet 100 mg,L01XK01
11528R,Oral,Oral,Targeted,OLAPARIB,Tablet 150 mg,L01XK01
09343R,Oral,Oral,Targeted,DASATINIB,Tablet 100 mg,L01EA02
09116T,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
09115R,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11745E,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
04610P,IV,Parenteral,Chemotherapy,RALTITREXED,Powder for I.V. infusion 2 mg in single use vial,L01BA03
12091J,Oral,Oral,Targeted,LORLATINIB,Tablet 100 mg,L01ED05
10583B,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 100 mg in 10 mL,L01XC02
11791N,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11811P,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
11801D,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11506N,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
11251E,Oral,Oral,Targeted,LAPATINIB,Tablet 250 mg (as ditosilate monohydrate),L01EH01
04713C,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
10323H,Oral,Oral,Targeted,CRIZOTINIB,Capsule 200 mg,L01ED01
11763D,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11648C,Oral,Oral,Targeted,VENETOCLAX,Tablet 50 mg,L01XX52
10721G,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
11660Q,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11116C,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11119F,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11115B,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11673J,IV,Parenteral,Targeted,INOTUZUMAB OZOGAMICIN,Powder for I.V. infusion 1 mg,L01XC26
09173T,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
11957H,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 840 mg in 14 mL,L01XC32
11336P,Oral,Oral,Targeted,AFATINIB,Tablet 20 mg,L01EB03
02485T,Oral,Oral,Targeted,DASATINIB,Tablet 70 mg,L01EA02
09171Q,Oral,Oral,Targeted,NILOTINIB,Capsule 200 mg (as hydrochloride monohydrate),L01EA03
02818H,Oral,Oral,Targeted,EVEROLIMUS,Tablet 2.5 mg,L01EG02
10530F,Oral,Oral,Targeted,PONATINIB,Tablet 45 mg (as hydrochloride),L01EA05
12124D,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
10166C,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
12096P,Oral,Oral,Targeted,LORLATINIB,Tablet 25 mg,L01ED05
07241D,Injection,Parenteral,Chemotherapy,ARSENIC,Injection concentrate containing arsenic trioxide 10 mg in 10 mL,L01XX27
11594F,Oral,Oral,Targeted,CRIZOTINIB,Capsule 250 mg,L01ED01
02963Y,Oral,Oral,Targeted,DABRAFENIB,Capsule 50 mg (as mesilate),L01EC02
11620N,Oral,Oral,Targeted,OSIMERTINIB,Tablet 40 mg,L01EB04
10022L,Oral,Oral,Targeted,ERLOTINIB,Tablet 25 mg (as hydrochloride),L01EB02
12128H,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11473W,IV,Parenteral,Targeted,OBINUTUZUMAB,Solution for I.V. infusion 1000 mg in 40 mL,L01XC15
10520Q,Oral,Oral,Targeted,PONATINIB,Tablet 15 mg (as hydrochloride),L01EA05
11871T,Oral,Oral,Targeted,ABEMACICLIB,Tablet 100 mg,L01EF03
11377T,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
11930X,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 840 mg in 14 mL,L01XC32
10817H,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
11802E,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11803F,IV,Parenteral,Targeted,BEVACIZUMAB,Solution for I.V. infusion 100 mg in 4 mL,L01XC07
09178C,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
05443L,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
12120X,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
12119W,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11880G,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11362B,Oral,Oral,Targeted,EVEROLIMUS,Tablet 5 mg,L01EG02
10042M,Oral,Oral,Targeted,PAZOPANIB,Tablet 200 mg (as hydrochloride),L01EX03
11780B,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
10240Y,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC10
11776T,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
11262R,Oral,Oral,Targeted,EVEROLIMUS,Tablet 10 mg,L01EG02
12161C,Oral,Oral,Targeted,OLAPARIB,Tablet 150 mg,L01XK01
11330H,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Powder for injection 50 mg,L01XC18
04725Q,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 3.5 mg,L01XG01
11505M,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
02478K,Oral,Oral,Targeted,DASATINIB,Tablet 20 mg,L01EA02
10464R,Oral,Oral,Targeted,SUNITINIB,Capsule 37.5 mg,L01EX01
02959R,Oral,Oral,Targeted,SUNITINIB,Capsule 25 mg,L01EX01
12127G,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11212D,IV,Parenteral,Chemotherapy,ERIBULIN,Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL,L01XX41
11329G,Oral,Oral,Targeted,AFATINIB,Tablet 50 mg,L01EB03
11341X,Oral,Oral,Targeted,AFATINIB,Tablet 30 mg,L01EB03
04371C,Injection,Parenteral,Chemotherapy,ARSENIC,Injection concentrate containing arsenic trioxide 10 mg in 10 mL,L01XX27
02448W,Oral,Oral,Chemotherapy,IDARUBICIN,Capsule containing idarubicin hydrochloride 10 mg,L01DB06
11367G,Oral,Oral,Targeted,CABOZANTINIB,Tablet 60 mg,L01EX07
11278N,IV,Parenteral,Chemotherapy,PRALATREXATE,Solution for I.V. infusion 20 mg in 1 mL,L01BA05
11765F,Oral,Oral,Targeted,IMATINIB,Tablet 400 mg (as mesilate),L01EA01
02482P,Oral,Oral,Targeted,DASATINIB,Tablet 50 mg,L01EA02
11756R,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
09174W,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11976H,Oral,Oral,Targeted,BRIGATINIB,Pack containing 7 tablets 90 mg and 21 tablets 180 mg,L01ED04
11589Y,Oral,Oral,Targeted,CRIZOTINIB,Capsule 200 mg,L01ED01
11800C,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
12163E,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
10925B,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11271F,IV,Parenteral,Chemotherapy,PRALATREXATE,Solution for I.V. infusion 20 mg in 1 mL,L01BA05
10935M,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
09172R,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
12123C,IV,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11813R,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 100 mg in 10 mL,L01XC02
11641Q,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 50 mg in 10 mL,L01XC11
12171N,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11266Y,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
10004M,Oral,Oral,Targeted,SUNITINIB,Capsule 12.5 mg,L01EX01
10915L,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
11781C,Oral,Oral,Targeted,IMATINIB,Tablet 100 mg (as mesilate),L01EA01
11770L,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
02643D,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 200 mg in 40 mL,L01XC11
09125G,Oral,Oral,Targeted,DASATINIB,Tablet 20 mg,L01EA02
11647B,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 50 mg in 10 mL,L01XC11
11870R,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
11335N,Oral,Oral,Targeted,AFATINIB,Tablet 20 mg,L01EB03
11079D,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
10811B,SC,Parenteral,Targeted,TRASTUZUMAB,Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL,L01XC03
11764E,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
10921T,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
05705G,IV,Parenteral,Chemotherapy,DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL,L01DB01
10252N,IV,Parenteral,Targeted,OFATUMUMAB,Solution concentrate for I.V. infusion 1000 mg in 50 mL,L01XC10
10920R,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
02446R,Oral,Oral,Chemotherapy,IDARUBICIN,Capsule containing idarubicin hydrochloride 5 mg,L01DB06
11635J,IV,Parenteral,Immunotherapy,NIVOLUMAB,Injection concentrate for I.V. infusion 100 mg in 10 mL,L01XC17
11984R,Oral,Oral,Targeted,BRIGATINIB,Tablet 180 mg,L01ED04
11118E,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11120G,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11117D,IV,Parenteral,Targeted,BLINATUMOMAB,Powder for I.V. infusion 38.5 micrograms,L01XC19
11591C,Oral,Oral,Targeted,EVEROLIMUS,"Tablet, dispersible, 2 mg",L01EG02
06249X,IV,Parenteral,Chemotherapy,DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL,L01DB01
11954E,Oral,Oral,Targeted,ENCORAFENIB,Capsule 50 mg,L01EC03
10939R,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
10171H,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
12155R,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 1200 mg in 20 mL,L01XC32
11783E,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
10917N,Oral,Oral,Targeted,IMATINIB,Capsule 400 mg (as mesilate),L01EA01
10924Y,Oral,Oral,Targeted,IMATINIB,Capsule 100 mg (as mesilate),L01EA01
11937G,Oral,Oral,Targeted,ENCORAFENIB,Capsule 50 mg,L01EC03
11790M,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11696N,IV,Parenteral,Targeted,INOTUZUMAB OZOGAMICIN,Powder for I.V. infusion 1 mg,L01XC26
04437M,Injection,Parenteral,Chemotherapy,FOTEMUSTINE,Powder for injection 208 mg with solvent,L01AD05
11531X,Oral,Oral,Targeted,MIDOSTAURIN,Capsule 25 mg,L01EX10
02663E,IV,Parenteral,Immunotherapy,IPILIMUMAB,Injection concentrate for I.V. infusion 200 mg in 40 mL,L01XC11
11820D,Oral,Oral,Targeted,DABRAFENIB,Capsule 50 mg (as mesilate),L01EC02
11876C,Oral,Oral,Targeted,ABEMACICLIB,Tablet 50 mg,L01EF03
11096B,IV,Parenteral,Targeted,BRENTUXIMAB VEDOTIN,Powder for I.V. infusion 50 mg,L01XC12
11940K,IV,Parenteral,Immunotherapy,ATEZOLIZUMAB,Solution concentrate for I.V. infusion 840 mg in 14 mL,L01XC32
11804G,IV,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
11624T,Oral,Oral,Targeted,VENETOCLAX,Tablet 10 mg,L01XX52
10346M,IV,Parenteral,Targeted,TRASTUZUMAB,Powder for I.V. infusion 60 mg,L01XC03
11942M,SC,Parenteral,Targeted,RITUXIMAB,Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL,L01XC02
12227M,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
12169L,Oral,Oral,Targeted,OLAPARIB,Tablet 100 mg,L01XK01
12232T,Oral,Oral,Targeted,OSIMERTINIB,Tablet 80 mg,L01EB04
12129J,Injection,Parenteral,Immunotherapy,PEMBROLIZUMAB,Solution concentrate for I.V. infusion 100 mg in 4 mL,L01XC18
11936F,Injection,Parenteral,Targeted,RITUXIMAB,Solution for I.V. infusion 500 mg in 50 mL,L01XC02
12221F,Injection,Parenteral,Targeted,DARATUMUMAB,Solution concentrate for I.V. infusion 100 mg in 5 mL,L01XC24
12219D,Injection,Parenteral,Chemotherapy,BORTEZOMIB,Powder for injection 1 mg,L01XG01
